🇺🇸Stock Analyst🔥 🔥

🔥US market: endless potential, direction defines winners. 🔥Level up your trading—follow elite-level guidance. 🔥Click: 👉wa.me/12138686055 🔥Inside our WhatsApp group: sharp trends, no-BS strategies, real-time profit alerts. #Stocks #Trading #Investing #wealthbuilding

I'm conducting live trading in a WhatsApp group! I will share every trade I make in my WhatsApp group, including the exact entry and exit points. Stock market enthusiasts are welcome to join! 👇 👇 wa.me/12138686055 Limited spots available, first come, first served!

$INTS 2025 milestones; $20M+ funding; Phase 2 amendment; Nasdaq extension. Strengths: DfuseRx anti-cancer; INT230-6 95% necrosis; cash to '27 Q2. Rise Today: From 3.18% gain; clinical optimism; funding confidence.

$CGNX News: Q4 '25 revenue $252M (+10%), EPS $0.27 beat; $500M buyback, dividend. Strengths: AI vision leader; 99.9% accuracy; $642M cash, no debt. Rise Today: Earnings surprise drove 25.15% jump; strong '26 outlook.

$GNLN Company: Cannabis accessories, vaporizers, crypto diversification. Strengths: Diverse brands, global distribution, innovative health/crypto products. Recent News: BERA token agreements signed Feb 4/9, 2026. Rise Today: +28.25% after-hours to $1.18, crypto momentum.

$TDC $TDC data analytics platform; scalable MPP, AI/ML integration; hybrid cloud, 40+ years expertise. Q4 revenue $421M (+3%); EPS $0.74 beat; FY26 guidance EPS $2.55-2.65; AI agents launched. Stock +17.52% to $34.35; earnings beat, optimistic guidance, AI traction.

$MNTN CTV ad platform; AI tools, self-serve; high margins (75-80%); CEO Mark Douglas, CCO Ryan Reynolds. Q4 2025 revenue $87M (+36%); EBITDA $28M; 3,632 clients; 2026 guidance $345-355M revenue. Stock +32.23% to $10.57; Q4 EPS beat ($0.43 vs $0.23); strong growth, cash $210M.

$QNCX Stock Surge: Up 85.15% to $0.2407 pre-market; notable intraday gains. Strategic Impact: LifeSci Capital explores M&A/sale options; optimism boosts shareholder value. Market Boost: Oversold RSI spurs buying; volume rise strengthens rally.

$MBOT 2026 milestones: SIR full launch, >$4M revenue; $630K IIA grant for manufacturing. Strong IP (13 patents), global expansion via CE Mark by 2026 end. Recent grants, IP gains fuel speculative rebound from $1.62 low.

$FEED RSU grant; Series H funding; U-Deliver distro; VP appoint; ENFit launch; name change. Innovative ENvue tech; FDA cleared; non-invasive devices; partnerships; market expansion. Today's Rise: SEC filing buzz; distro optimism; speculative buys; 23.63% gain.

$ARTL ~$1.47-1.61; Strong Buy, target $11.50-30.60. Nasdaq compliance extension; $50M financing; CBD praise. Lipid therapies pipeline; Clinical progress; IP and partnerships. Rise: Compliance relief, funding optimism.

$TNON up 19.53% to $0.85-0.88; Strong Buy, target $3. Q4 rev +90%, full year +20%; New SImmetry+ system; $2.85M financing. Innovative SI fusion tech; High fusion rates; Market expansion. Rise: Earnings guidance optimism.

$QNST AI-driven marketplace; strong growth; resilient position; acquisition potential. Q2 FY26 earnings beat; HomeBuddy acquisition; AI enhancements. Today's Rise: Up 22.6%; earnings reaction; acquisition boost; breakout.

$RBLX Leading UGC game platform, strong user & creator ecosystem. Q4 2025 Earnings: Revenue $1.42B (+43%), DAU 144M (+69%). 2026 Guidance: Bookings $8.28-8.55B, Revenue $6.02-6.29B. Stock Rise: +9.44% due to beats & optimistic outlook.

$WHLR Grocery-anchored REIT in Southeast US; low-competition markets; strong cash flow; debt optimization. Q3 2025 earnings up; preferred stock redemptions; convertible notes adjusted. Today's Surge: Up 36.07%; thin float, speculation; no clear catalyst.

$BNAI surged 26.99%. Driven by termination of $50M equity purchase agreement. Reduces dilution risk, strengthens balance sheet. Combined with completed private placement. Signals improved capital discipline and financial control. Sparked strong investor confidence.

$NXL News: Peer-reviewed DIFS studies; Nasdaq non-compliance; FDA meeting; Q3 revenue drop. Strengths: Patented neurostimulation; FDA approvals; Strong liquidity; 52% revenue growth. Rise: Neuroimaging news drove 17.47% pre-market; High volume squeeze.

$CISS News: Acquired two MR tankers; 1-for-20 reverse split; Imperial holds 81.9%. Strengths: Debt-free; Fleet up 230%; 17% ROE. Rise: Ownership filing triggered 38.16% pre-market gain.

$SMCI Recent News: Q2 rev $12.7B (+123% YoY); FY26 guidance $4B+; NVIDIA Rubin support. Company Strengths: AI/GPU servers; modular/liquid-cooled designs; $13B backlog; NVIDIA partnerships. Today's Surge: Earnings beat; AI demand; guidance uptick (10.55% rise).